TMO adds a diagnostics leader

Article Excerpt

THERMO FISHER SCIENTIFIC INC., $536.01, is a buy. The company (New York symbol TMO; TSINetwork Rating: Average) thermofisher.com; Shares o/s: 392.2 million; Market cap: $214.2 billion; Dividend yield: 0.2%) recently bought The Binding Site Group, a global leader in specialty diagnostics, for $2.6 billion. Serving clinicians and laboratory professionals worldwide, The Binding Site provides specialty diagnostics and instruments to better pinpoint and manage blood cancers and immune system disorders. Headquartered in Birmingham, U.K., The Binding Site has more than 1,100 employees globally. It has reported annual sales of more than $220 million and is expected to add $0.07 a share to Thermo Fisher’s annual earnings. Thermo Fisher is a buy. buy. …